Friday, January 22, 2021
- Advertisement -

TAG

NASDAQ:PACB

why Pacific Biosciences of California Inc. [PACB] is a Good Choice for Investors After New Price Target of $18.40

Pacific Biosciences of California Inc. jumped around 3.37 points on Thursday, while shares priced at $37.72 at the close of the session, up...

why Pacific Biosciences of California Inc. [PACB] is a Good Choice for Investors After New Price Target of $17.40

Pacific Biosciences of California Inc. price plunged by -1.16 percent to reach at -$0.25. The company report on December 14, 2020 that Leading...

Piper Sandler slashes price target on Pacific Biosciences of California Inc. [PACB] – find out why.

Pacific Biosciences of California Inc. traded at a high on 11/27/20, posting a 6.12 gain after which it closed the day’ session at...

Pacific Biosciences of California Inc. [PACB] moved up 12.35: Why It’s Important

Pacific Biosciences of California Inc. gained 12.35% on the last trading session, reaching $16.47 price per share at the time. The company report...

why Pacific Biosciences of California Inc. [PACB] is a Good Choice for Investors After New Price Target of $13.20

Pacific Biosciences of California Inc. gained 4.95% or 0.69 points to close at $14.64 with a heavy trading volume of 2123773 shares. The...

Pacific Biosciences of California Inc. [PACB] stock Upgrade by JP Morgan analyst, price target now $15

Pacific Biosciences of California Inc. stock went on a downward path that fall over -2.81% on Monday, amounting to a one-week price increase...

Market cap of Pacific Biosciences of California Inc. [PACB] reaches 1.55B – now what?

Pacific Biosciences of California Inc. stock went on an upward path that rose over 3.82% on Friday, amounting to a one-week price increase...

Market cap of Pacific Biosciences of California Inc. [PACB] reaches 1.19B – now what?

Pacific Biosciences of California Inc. closed the trading session at $6.97 on 09/10/20. The day’s price range saw the stock hit a low...

Pacific Biosciences of California Inc. [PACB] is 25.49% higher this YTD. Is it still time to buy?

Pacific Biosciences of California Inc. price plunged by -3.15 percent to reach at -$0.21. The company report on August 12, 2020 that Pacific...

Pacific Biosciences of California Inc. [PACB] moved down -0.42: Why It’s Important

Pacific Biosciences of California Inc. closed the trading session at $4.71 on 08/10/20. The day’s price range saw the stock hit a low...

Latest news

why PACCAR Inc [PCAR] is a Good Choice for Investors After New Price Target of $95.59

PACCAR Inc surged by $9.35 during the normal trading session on Thursday and reaching a high of $103.19 during the day while it...

Astrotech Corporation [ASTC] Stock trading around $2.33 per share: What’s Next?

Astrotech Corporation traded at a high on 01/21/21, posting a 8.88 gain after which it closed the day’ session at $2.33. The company...

Editas Medicine Inc. [EDIT] fell -9.01% so far this year. What now?

Editas Medicine Inc. price plunged by -11.11 percent to reach at -$7.97. The company report on January 21, 2021 that Editas Medicine Announces...

Market cap of Creative Realities Inc. [CREX] reaches 18.71M – now what?

Creative Realities Inc. gained 9.32% or 0.15 points to close at $1.76 with a heavy trading volume of 1686949 shares. The company report...

Acamar Partners Acquisition Corp. [ACAM] is 9.82% higher this YTD. Is it still time to buy?

Acamar Partners Acquisition Corp. closed the trading session at $12.30 on 01/21/21. The day’s price range saw the stock hit a low of...
- Advertisement -

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.